跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 37,044 条关于
“Xcell Biosciences Australia”
全部
37,044
临床试验
28,203
药物
3,051
机构
787
资讯
5,003
去年
Tumor-Infiltrating Lymphocyte Therapy Market Poised for Explosive Growth Following First FDA Approval
去年
NewBiologix Licenses High-Yield HEK293 Cell Line to ReciBioPharm for Advanced AAV Gene Therapy Production
16天前
NewBiologix and Synastra Partner to Advance Stable rAAV Manufacturing for Duchenne Muscular Dystrophy Gene Therapy
去年
Toripalimab Approved in Australia for Nasopharyngeal Carcinoma
去年
Australia Approves IFINWIL (Eflornithine) for High-Risk Neuroblastoma Treatment
3个月前
Western Australia Launches $2 Million Cardiovascular Research Fellowship Partnership
去年
Summit Therapeutics' Ivonescimab Shows Promising Results in Lung Cancer Trial, Co-CEO Becomes Billionaire
去年
Percheron Therapeutics Discontinues Avicursen Trial for Duchenne Muscular Dystrophy After Phase 2 Failure
上个月
US–Australia Collaboration Aims to Accelerate Early-Stage Clinical Trials and Strengthen American Biotech Competitiveness
2个月前
Anixa Biosciences Wins Australian Patent Acceptance for Breast Cancer Vaccine, Expanding Global IP Estate
第 1 页，共 501 页
上一页
下一页
